United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 14, 2026 · Filed May 15, 2026

On May 14, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$574.48 for US$5.74M under a trading plan, leaving 18,876 shares. Filed May 15, 2026 (Form 4).

Sold
10,000 shares
Price
US$574.48 average (US$568.74 to US$578.59)
Value
US$5.74M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockOption exercise10,000US$135.4228,876Direct
May 14, 2026Common StockSale80US$568.7428,796Direct
May 14, 2026Common StockSale80US$570.5228,716Direct
May 14, 2026Common StockSale603US$571.5328,113Direct
May 14, 2026Common StockSale970US$572.7827,143Direct
May 14, 2026Common StockSale2,456US$574.0424,687Direct
May 14, 2026Common StockSale3,419US$574.7621,268Direct
May 14, 2026Common StockSale1,712US$575.7819,556Direct
May 14, 2026Common StockSale293US$576.7519,263Direct
May 14, 2026Common StockSale307US$577.9318,956Direct
May 14, 2026Common StockSale80US$578.5918,876Direct

Source

View original at SEC

Related